Ignite-branded products to be offered for sale in Canada by WeedMD in two-year deal
Marijuana Investing
FDA Cracks Down on Curaleaf over CBD ‘Drugs’
Curaleaf is not allowed to sell many of its CBD products online. Why not? Because the FDA continues to get in the way.
Lexaria Bioscience and Hill Street Beverage Co. Announce Global Manufacturing & Licensing Partnership
Lexaria Bioscience teams up with Hill Street Beverages for global partnership in premium cannabis-infused beverages
Delta 9 Signs One-Year Agreement for White Label Cannabis Derivative Manufacturing with Westleaf
Delta 9 will supply Westleaf with approximately $4 million in cannabis derivative products
CBD-Rich Hemp Biomass: a NEW Profit Generator in the Cannabis Space
MYM's sale of CAD$25 million in CBD-rich hemp biomass has the Company on track to meet revenue/profit targets.
IONIC BRANDS COMPLETES ACQUISITION OF ZOOTS - PREMIUM CANNABIS-INFUSED EDIBLES AND INFUSED PRODUCTS
IONIC closes on Zoots. Its premium edibles are available in Washington, Colorado, Illinois and Massachusetts and are expected to add US$3.0 million to IONIC's 2019 revenues.
Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction Capabilities
Neptune's acquisition of Sugarleaf creates a "leading North American extraction platform"
Rocky Mountain High Brands Announces an Agreement to Distribute Hemp-Derived CBD Products for Home and Office Delivery
Rocky Mountain High Brands teams up with Water Event to distribute CBD products in Texas
YIELD GROWTH Announces Patent Pending Manufacturing Technique Yields High Terpenes from Hemp
Yield Growth's patent-pending processing of hemp root oil is yielding high terpene levels
MYM’s Joint Venture Company BioHemp Signs LOI for the Sale of $25 Million of CBD-Rich Hemp Biomass
MYM Nutraceuticals' $25 million LOI with BioHemp Naturals represents nearly half of MYM's remaining forecasted sales
Sunniva Announces Kevin Wilkerson Assumes Role As President Of Sunniva Inc. , Focus ShiftingTo Its High Value California Operations
Sunniva's new President Kevin Wilkerson will continue the shift to high-value California operations
MYM’s Joint Venture Company BioHemp Signs LOI for the Sale of $25 Million of CBD-Rich Hemp Biomass
MYM Nutraceuticals' $25 million LOI with BioHemp Naturals represents nearly half of MYM's remaining forecasted sales
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction
NASDAQ-listed Therapix Biosciences to merge with Alberta-based Destiny Bioscience Global